Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A new study finds that inherited genetic variation plays a role in who is likely to benefit from cancer immunotherapies.
New research shows that gene activity could be used to predict tumors most likely to benefit from “genotoxic” therapies
A genomic study has uncovered molecular changes in tumors that may lead to dramatic and long-lasting responses to cancer therapy.
Those who reported either an increase or decrease in imbibing were more likely to experience stress and anxiety.
Recent studies on acral melanoma presented at the 2020 Melanoma Research Alliance Scientific Retreat are showing promising findings.
Researchers found that aggressive Gleason grade group 5 prostate cancer has different subtypes with varying risks.
Doctors have used immunotherapy to treat a variety of cancers for almost five decades, and results continue to be encouraging.
Understanding the genetics of an infectious tumor in Tasmanian devils could point toward new treatment targets.
The molecular biologist was the first to clone HIV, and she helped prove that the virus causes AIDS. She also researched cancer genetics.
NCI awards Fred Hutch $3.5M to create a colorectal cancer risk calculator based on data from multiethnic populations.
These cancers include those that are rare among adults under 40, such as breast, colon, pancreas, kidney, prostate and ovarian cancer.
Researchers analyzed how a combination of cancer treatments and inherited mutations in DNA-repair genes predicted new cancers.
The maps may create opportunities to identify cancers much earlier than is currently possible, the study leaders believe.
In light of the new findings, “we are thinking about how we can target all this extra DNA that’s important on these circles.”
By combining the tools of pathology, computational modeling and genomics, the project hopes to discover and test therapeutic interventions.
If the disease is caught early, survival rates increase dramatically, underscoring the need to identify those who may be at risk.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.